Prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis

BACKGROUND This retrospective study investigates factors affecting surgical and oncological outcome after performing pancreaticoduodenectomy in octogenarian patients diagnosed with pancreatic ductal adenocarcinoma. METHODS From January 2009 to December 2018, patients who underwent pancreaticoduodenectomy for pancreatic ductal adenocarcinoma were included. Data were analysed by comparing clinicopathological characteristics, complications, survival, recurrence, adjuvant treatment between octogenarians and the younger group. Propensity score matched analysis was performed due to the small size of the octogenarian group. RESULTS A total of 666 patients were included in this study and 24 (3.6%) were included in the octogenarian group. Short term complication rates (P = 0.119) and hospital stay (P = 0.839) did not differ between two groups. Overall survival between the two groups showed significant difference (<80 median 25 months versus ≥80 median 13 months, P = 0.045). However, after propensity score matched analysis, the two groups did not differ in overall survival (<80 median 18 months versus ≥80 median survival 16 months, P = 0.565) or disease-free survival (P = 0.471). Among the octogenarians, six patients survived longer than 24 months even without satisfying all favourable prognostic factors. CONCLUSION Considering the general condition of octogenarians diagnosed with pancreatic ductal adenocarcinoma, select patients should be treated more aggressively for the best chance of receiving curative treatment.

[1]  G. Kazemier,et al.  Short- and Long-Term Outcomes of Pancreatic Cancer Resection in Elderly Patients: A Nationwide Analysis , 2022, Annals of Surgical Oncology.

[2]  C. Lepage,et al.  Management and Outcomes of Pancreatic Cancer in French Real-World Clinical Practice , 2022, Cancers.

[3]  J. Winter,et al.  Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database Analysis , 2021, Journal of Gastrointestinal Surgery.

[4]  W. Uhl,et al.  Long-term survival after pancreaticoduodenectomy in patients with ductal adenocarcinoma of the pancreatic head. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[5]  Jin‐Young Jang,et al.  Short- and long-term outcomes of pancreaticoduodenectomy in elderly patients with periampullary cancer , 2019, Annals of Surgical Treatment and Research.

[6]  C. V. van Eijck,et al.  Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. , 2019, European journal of cancer.

[7]  C. Sandroussi,et al.  Postoperative outcomes in elderly patients undergoing pancreatic resection for pancreatic adenocarcinoma: A systematic review and meta-analysis. , 2019, International journal of surgery.

[8]  Sung-Sik Han,et al.  Surgery for elderly patients with resectable pancreatic cancer, a comparison with non-surgical treatments: a retrospective study outcomes of resectable pancreatic cancer , 2019, BMC Cancer.

[9]  E. Lee,et al.  Prediction of Cancer Incidence and Mortality in Korea, 2019 , 2019, Cancer research and treatment : official journal of Korean Cancer Association.

[10]  Song-Cheol Kim,et al.  Prognostic Value of Adjuvant Chemotherapy Following Pancreaticoduodenectomy in Elderly Patients With Pancreatic Cancer , 2019, AntiCancer Research.

[11]  L. Weinberg,et al.  Age 80 years and over is not associated with increased morbidity and mortality following pancreaticoduodenectomy , 2018, ANZ journal of surgery.

[12]  P. Liu,et al.  Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients. , 2018, International journal of surgery.

[13]  M. Abu Hilal,et al.  Elderly patients have similar short term outcomes and five-year survival compared to younger patients after pancreaticoduodenectomy. , 2017, International journal of surgery.

[14]  M. Tuveri,et al.  Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center , 2017, World journal of gastroenterology.

[15]  D. Gouma,et al.  The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After , 2017, Surgery.

[16]  E. Jensen,et al.  A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas , 2016, Cancer.

[17]  Jonathan C. King,et al.  Deviations from Expected Treatment of Pancreatic Cancer in Octogenarians: Analysis of Patient and Surgeon Factors , 2016, Annals of Surgical Oncology.

[18]  P. Kornprat,et al.  Pancreas Cancer Surgery in Octogenarians - Should We or Should We Not? , 2016, Anticancer Research.

[19]  G. Honda,et al.  Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study , 2016, Journal of hepato-biliary-pancreatic sciences.

[20]  V. Swaminathan,et al.  Geriatric oncology: problems with under-treatment within this population , 2015, Cancer biology & medicine.

[21]  S. Merigliano,et al.  Outcome of pancreaticoduodenectomy in octogenarians: Single institution's experience and review of the literature. , 2015, Journal of visceral surgery.

[22]  M. Millan,et al.  Treatment of colorectal cancer in the elderly. , 2015, World journal of gastrointestinal oncology.

[23]  A. Kwon,et al.  Potential role of surgical resection for pancreatic cancer in the very elderly. , 2015, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[24]  A. Gulbinas,et al.  Factors Influencing Survival after Pancreatoduodenectomy for Ductal Adenocarcinoma Depend on Patients' Age , 2015, Digestive Surgery.

[25]  R. Függer,et al.  Surgical quality data and survival after pancreatic cancer resections: a comparison of results for octogenarians and younger patients , 2014, Wiener klinische Wochenschrift.

[26]  P. Bachellier,et al.  Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. , 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[27]  N. Jamieson,et al.  The Prognostic Influence of Resection Margin Clearance Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma , 2013, Journal of Gastrointestinal Surgery.

[28]  I. Esposito,et al.  Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections , 2010, Cancers.

[29]  J. Chabot,et al.  Pancreaticoduodenectomy can be Performed Safely in Patients Aged 80 years and Older , 2010, Journal of Gastrointestinal Surgery.

[30]  C. Ko,et al.  Validation of the 6th edition AJCC pancreatic cancer staging system , 2007, Cancer.

[31]  M. Makary,et al.  Pancreaticoduodenectomy in the very elderly , 2006, Journal of Gastrointestinal Surgery.

[32]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[33]  D. Gouma,et al.  Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. , 2004, European journal of cancer.

[34]  C. Su,et al.  Is pancreaticoduodenectomy justified for septuagenarians and octogenarians? , 2003, Hepato-gastroenterology.

[35]  David Cella,et al.  Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. , 2002, Journal of the National Cancer Institute.

[36]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[37]  M. Oliveira-Cunha,et al.  Results of pancreatic surgery in the elderly: is age a barrier? , 2013, HPB : the official journal of the International Hepato Pancreato Biliary Association.